Could you give me some smaller notes? http://conankun.net/page/3/ chlorpromazine (thorazine) drug study Brean Capital analyst Gene Mack said in a note dated Sept. 5that Astex should have rejected an offer below $13 per share asit did not reflect the royalties from its drug Dacogen and itsportfolio of drugs partnered with companies including NovartisAG.